title: Consensus statement on the treatment of septic shock.
authors.affiliation: Intensieve Geneeskunde A.Z. VU Brussel, Belgium.
authors.forename: H
authors.initials: H
authors.lastname: Spapen
authors.forename: P
authors.initials: P
authors.lastname: Damas
authors.forename: V
authors.initials: V
authors.lastname: D'Orio
authors.forename: M
authors.initials: M
authors.lastname: Sabbe
authors.forename: D
authors.initials: D
authors.lastname: Vogelaers
authors.forename: B
authors.initials: B
authors.lastname: Byl
authors.forename: D
authors.initials: D
authors.lastname: Knockaert
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001530:Belgium; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D005440:Fluid Therapy; D006801:Humans; D007167:Immunotherapy; D009747:Nutritional Physiological Phenomena; D010437:Peptic Ulcer / Q000517:prevention & control; D012138:Respiratory Therapy; D018805:Sepsis / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy*; D013312:Stress, Physiological / Q000517:prevention & control; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents; D002316:Cardiotonic Agents; D014662:Vasoconstrictor Agents; D004298:Dopamine